Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 HKD | +1.05% | +2.85% | -16.71% |
30/04 | Wall Street, Earnings, Federal Reserve Roil Asian Stock Markets | MT |
30/04 | Sino Biopharmaceutical Limited Announces Approval for Marketing of Category 1 Unecritinib Fumarate Capsules | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.71% | 6.74B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- 1177 Stock
- News Sino Biopharmaceutical Limited
- Sino Biopharmaceutical : Receives Registration Approval for Cancer Treatment in China